Inaguma Daijo, Ito Eri, Takahashi Kazuo, Hayashi Hiroki, Koide Shigehisa, Hasegawa Midori, Yuzawa Yukio
Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Clin Exp Nephrol. 2018 Dec;22(6):1360-1370. doi: 10.1007/s10157-018-1592-0. Epub 2018 Jun 7.
An increasing number of patients worldwide require dialysis as a result of hypertensive nephrosclerosis (HTN). However, in Japan, mortality in patients with end-stage renal disease (ESRD) has not been well by primary kidney disease including HTN and diabetic nephropathy (DN). Hence, we examined the differences in mortality among the primary kidney diseases of incident dialysis patients.
The study was a multicenter prospective cohort analysis including 1520 incident dialysis patients in Aichi prefecture, Japan. We classified patients into three groups according to the primary kidney disease [i.e., a HTN group, n = 384, a DN group n = 658, and a chronic glomerulonephritis (CGN) group, n = 224]. In addition, we classified patients into the HTN group and the DN group using propensity score matching. We compared outcomes including all-cause and infection-related mortality.
The mortality rates of the HTN, the DN, and the CGN group, were 135.9, 64.2, and 34.8 per 1000 patient years, respectively. All-cause mortality and infection-related mortality rates in the HTN group were as high as those in the DN group after adjustment for age, gender, history of cardiovascular disease, and estimated glomerular filtration rate. No significant difference of all-cause mortality was observed after propensity score matching between the two groups (Logrank test: p = 0.523).
The present study was Japan's first large-scale prospective cohort to demonstrate that HTN is the second most common cause of ESRD. In addition, the prognosis of patients with HTN was as poor as that of patients with DN.
由于高血压性肾硬化(HTN),全球需要透析的患者数量日益增加。然而,在日本,终末期肾病(ESRD)患者的死亡率在包括HTN和糖尿病肾病(DN)在内的原发性肾脏疾病中并未得到很好的体现。因此,我们研究了初诊透析患者原发性肾脏疾病之间的死亡率差异。
本研究为多中心前瞻性队列分析,纳入了日本爱知县的1520例初诊透析患者。我们根据原发性肾脏疾病将患者分为三组[即HTN组,n = 384;DN组,n = 658;慢性肾小球肾炎(CGN)组,n = 224]。此外,我们使用倾向得分匹配将患者分为HTN组和DN组。我们比较了包括全因死亡率和感染相关死亡率在内的结局。
HTN组、DN组和CGN组的死亡率分别为每1000患者年135.9、64.2和34.8例。在调整年龄、性别、心血管疾病史和估计肾小球滤过率后,HTN组的全因死亡率和感染相关死亡率与DN组一样高。两组倾向得分匹配后,全因死亡率无显著差异(对数秩检验:p = 0.523)。
本研究是日本首个大规模前瞻性队列研究,证明HTN是ESRD的第二大常见病因。此外,HTN患者的预后与DN患者一样差。